Jag Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7M Buy
22,275
+18
+0.1% +$18.4K 2.5% 11
2026
Q1
$20.5M Buy
22,257
+1,206
+6% +$1.22M 2.3% 14
2025
Q4
$22.6M Buy
21,051
+7,481
+55% +$7.15M 2.45% 12
2025
Q3
$10.4M Sell
13,570
-11,047
-45% -$8.22M 1.13% 28
2025
Q2
$19.2M Buy
24,617
+273
+1% +$212K 2.15% 16
2025
Q1
$20.1M Buy
24,344
+8,871
+57% +$7.38M 2.68% 12
2024
Q4
$11.9M Sell
15,473
-12,100
-44% -$10M 1.67% 24
2024
Q3
$24.4M Buy
27,573
+1,374
+5% +$1.24M 2.95% 10
2024
Q2
$23.7M Sell
26,199
-226
-0.9% -$181K 3.25% 8
2024
Q1
$20.6M Sell
26,425
-1,145
-4% -$815K 2.91% 9
2023
Q4
$16.1M Sell
27,570
-4,340
-14% -$2.53M 2.46% 17
2023
Q3
$17.1M Buy
31,910
+852
+3% +$439K 2.07% 16
2023
Q2
$14.6M Buy
31,058
+6,549
+27% +$2.75M 1.68% 23
2023
Q1
$8.42M Sell
24,509
-13,367
-35% -$4.51M 1.09% 32
2022
Q4
$13.9M Sell
37,876
-3,743
-9% -$1.33M 2.01% 17
2022
Q3
$13.5M Sell
41,619
-3,099
-7% -$982K 1.88% 16
2022
Q2
$14.5M Buy
44,718
+43,403
+3,301% +$13M 1.79% 15
2022
Q1
$246K Sell
1,315
-54,662
-98% -$14.1M 0.02% 193
2021
Q4
$15.5M Buy
55,977
+3,002
+6% +$761K 1.19% 30
2021
Q3
$12.2M Buy
52,975
+51,657
+3,919% +$12.7M 0.95% 32
2021
Q2
$302K Buy
1,318
+3
+0.2% +$603 0.02% 201
2021
Q1
$246K Buy
+1,315
New +$257K 0.02% 204
2020
Q3
Sell
-1,701
Closed -$279K 180
2020
Q2
$279K Hold
1,701
0.03% 147
2020
Q1
$236K Hold
1,701
0.03% 151
2019
Q4
$224K Buy
+1,701
New +$197K 0.03% 185
2019
Q2
Sell
-157,962
Closed -$20.5M 197
2019
Q1
$20.5M Buy
157,962
+13,680
+9% +$1.66M 3.34% 5
2018
Q4
$16.7M Buy
144,282
+10,105
+8% +$1.13M 3.4% 7
2018
Q3
$14.4M Buy
+134,177
New +$13.4M 2.36% 19
2017
Q3
Sell
-2,575
Closed -$212K 116
2017
Q2
$212K Hold
2,575
0.04% 108
2017
Q1
$217K Sell
2,575
-2,250
-47% -$180K 0.04% 105
2016
Q4
$355K Buy
+4,825
New +$359K 0.07% 106

Other funds holding LLY

Jag Capital Management's LLY Position: Q2 2026 in Review

Jag Capital Management increased its Eli Lilly (LLY) stake by 0.08% in Q2 2026, buying an estimated $18.4K and bringing the position to 22,275 shares worth $26.7M. The position accounts for 2.5% of the portfolio, ranked #11.

Jag Capital Management first reported a position in LLY in Q4 2016 and has held it in 31 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jag Capital Management held 22,275 shares of Eli Lilly worth $26.7M as of Q2 2026.
  • Jag Capital Management bought 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 2.5% of Jag Capital Management's portfolio in Q2 2026, its #11 holding.
  • Jag Capital Management first reported a position in Eli Lilly in Q4 2016 and has held it in 31 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jag Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.